Literature DB >> 19434463

Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET.

Mitsuaki Tatsumi1, Christian Cohade, Robert E Bristow, Richard L Wahl.   

Abstract

PURPOSE: To compare 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) and PET/computed tomography (CT) for certainty of image interpretation and for diagnostic accuracy in patients with primary and metastatic uterine cervical cancer.
MATERIALS AND METHODS: Images of 13 patients with cervical cancer having PET/CT examinations were reviewed retrospectively. PET and PET/CT images of all cases were read blindly and randomly by two readers. Foci of increased FDG uptake on PET or PET/CT were classified using a scoring system regarding lesion localization and characterization. PET and PET/CT findings were assessed with all clinical information available, and diagnostic accuracy was determined on a per-lesion and on a per-patient basis.
RESULTS: For both readers, PET/CT provided significantly higher frequencies of definite lesion localization (>30% higher) and definite lesion characterization (>20% higher) compared to the findings on PET alone. The improvement in lesion localization to the definite level by PET/CT provided the definite lesion characterization in at least 50% of cases. PET/CT tended to exhibit higher diagnostic accuracy than PET alone on a lesion-based analysis (92% vs. 78% in reader 1 and 92% vs. 82% in reader 2, respectively). Metastatic disease spread was, however, almost equally evaluated between PET and PET/CT.
CONCLUSION: PET/CT was demonstrated to be useful in the definite localization and characterization of foci of increased FDG uptake, which provided its higher diagnostic accuracy than PET alone. PET/CT appears preferable to PET in the evaluation of cervical cancer, although additional study is needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434463     DOI: 10.1007/s11307-008-0180-1

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  12 in total

Review 1.  A tabulated summary of the FDG PET literature.

Authors:  S S Gambhir; J Czernin; J Schwimmer; D H Silverman; R E Coleman; M E Phelps
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

2.  Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.

Authors:  P G Rose; L P Adler; M Rodriguez; P F Faulhaber; F W Abdul-Karim; F Miraldi
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

3.  Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.

Authors:  Yuji Nakamoto; Avraham Eisbruch; Eric D Achtyes; Yoshifumi Sugawara; Kevin R Reynolds; Carolyn M Johnston; Richard L Wahl
Journal:  Gynecol Oncol       Date:  2002-02       Impact factor: 5.482

4.  Evaluation of FDG PET in patients with cervical cancer.

Authors:  Y Sugawara; A Eisbruch; S Kosuda; B E Recker; P V Kison; R L Wahl
Journal:  J Nucl Med       Date:  1999-07       Impact factor: 10.057

5.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.

Authors:  P W Grigsby; B A Siegel; F Dehdashti
Journal:  J Clin Oncol       Date:  2001-09-01       Impact factor: 44.544

6.  Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.

Authors:  Gerald Antoch; Jörg Stattaus; Andre T Nemat; Simone Marnitz; Thomas Beyer; Hilmar Kuehl; Andreas Bockisch; Jörg F Debatin; Lutz S Freudenberg
Journal:  Radiology       Date:  2003-09-25       Impact factor: 11.105

7.  Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Ichio Fukasawa; Noriyuki Inaba; Narufumi Suganuma; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

8.  Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma.

Authors:  Christian Cohade; Medhat Osman; Jeffrey Leal; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-11       Impact factor: 10.057

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer.

Authors:  Ukihide Tateishi; Tetsuo Maeda; Tsuyoshi Morimoto; Mototaka Miyake; Yasuaki Arai; E Edmund Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

View more
  2 in total

1.  The incremental value of dual modality PET/CT imaging over PET imaging alone in advanced colorectal cancer.

Authors:  A H Engledow; G E L Bond-Smith; D Francis; F Pakzad; J Bomanji; A Groves; P J Ell
Journal:  Indian J Surg       Date:  2009-05-02       Impact factor: 0.656

Review 2.  Current molecular imaging positron emitting radiotracers in oncology.

Authors:  Aizhi Zhu; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2011-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.